GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vapotherm Inc (OTCPK:VAPO) » Definitions » Days Sales Outstanding

Vapotherm (Vapotherm) Days Sales Outstanding : 41.88 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Vapotherm Days Sales Outstanding?

Vapotherm's average Accounts Receivable for the three months ended in Dec. 2023 was $9.06 Mil. Vapotherm's Revenue for the three months ended in Dec. 2023 was $19.73 Mil. Hence, Vapotherm's Days Sales Outstanding for the three months ended in Dec. 2023 was 41.88.

The historical rank and industry rank for Vapotherm's Days Sales Outstanding or its related term are showing as below:

VAPO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.06   Med: 56.83   Max: 71.3
Current: 47.34

During the past 8 years, Vapotherm's highest Days Sales Outstanding was 71.30. The lowest was 46.06. And the median was 56.83.

VAPO's Days Sales Outstanding is ranked better than
73.23% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.19 vs VAPO: 47.34

Vapotherm's Days Sales Outstanding declined from Dec. 2022 (42.14) to Dec. 2023 (41.88).


Vapotherm Days Sales Outstanding Historical Data

The historical data trend for Vapotherm's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vapotherm Days Sales Outstanding Chart

Vapotherm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial 58.24 46.06 55.41 54.67 52.55

Vapotherm Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.14 45.04 49.28 49.21 41.88

Competitive Comparison of Vapotherm's Days Sales Outstanding

For the Medical Devices subindustry, Vapotherm's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vapotherm's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vapotherm's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Vapotherm's Days Sales Outstanding falls into.



Vapotherm Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Vapotherm's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (9.102 + 10.672) / 2 ) / 68.669*365
=9.887 / 68.669*365
=52.55

Vapotherm's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (7.441 + 10.672) / 2 ) / 19.734*365 / 4
=9.0565 / 19.734*365 / 4
=41.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vapotherm  (OTCPK:VAPO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Vapotherm Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Vapotherm's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Vapotherm (Vapotherm) Business Description

Traded in Other Exchanges
N/A
Address
100 Domain Drive, Exeter, NH, USA, 03833
Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. It generates revenue primarily from sales of proprietary Precision Flow systems to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.
Executives
Joseph Army director, officer: President and CEO ONE WASHINGTON CENTER, SUITE 400, DOVER NH 03820
Anthony L. Arnerich director 100 DOMAIN DRIVE, EXETER NH 03833
Dorota Mckay officer: Chief Accounting Officer 100 DOMAIN DRIVE, EXETER NH 03833
John Landry officer: See Remarks 100 DOMAIN DRIVE, EXETER NH 03833
James W Liken director 5 DEER SPRING LANE, PITTSBURGH PA 15211
Lance A Berry director 5677 AIRLINE ROAD, ARLINGTON TN 38002
Elizabeth H Weatherman director C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Richard R Barrera 10 percent owner 767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Roystone Capital Holdings Llc 10 percent owner 767 THIRD AVENUE, 29TH FLOOR, NEW YORK NY 10017
Roystone Capital Management Lp 10 percent owner 780 THIRD AVENUE, 41ST FLOOR, NEW YORK NY 10017
Brian Lawrence officer: SVP & Chief Technology Officer 100 DOMAIN DRIVE, EXETER NH 03833
Prescott General Partners Llc 10 percent owner, other: Member of Section 13(d) Group 2200 BUTTS ROAD, SUITE 320, BOCA RATON FL 33431
Gregoire Ramade officer: Vice President, International 100 DOMAIN DRIVE, EXETER NH 03833
Joel F. Dube officer: Chief Accounting Officer 100 DOMAIN DRIVE, EXETER NH 03833
Donald J Spence director C/O OAKMONT ACQUISITION CORP., 33 BLOOMFIELD HILLS PARKWAY, SUITE 240, BLOOMFIELD HILLS MI 48304